BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 4961005)

  • 1. [Complications during treatment of patients with malignant neoplasms of the larynx with antitumor preparations].
    Svetlakov MI; Kravchenko AA
    Zh Ushn Nos Gorl Bolezn; 1964; 24(4):10-4. PubMed ID: 4961005
    [No Abstract]   [Full Text] [Related]  

  • 2. [The morphologic composition of peripheral blood following intra-arterial infusion of 5-fluorouracil and alkylating preparations in stomach cancer patients].
    Chernyĭ VA
    Vopr Onkol; 1970 Apr; 16(4):61-4. PubMed ID: 4989339
    [No Abstract]   [Full Text] [Related]  

  • 3. [The hypoplastic state of hematopoiesis following chemotherapy with alkylating compounds].
    Kholodnyi MD; Mindlin SS
    Vopr Onkol; 1969; 15(8):27-32. PubMed ID: 4982329
    [No Abstract]   [Full Text] [Related]  

  • 4. [EXPERIENCE IN THE USE OF THIO-TEPA, DOPAN AND SARCOLYSIN IN THE TREATMENT OF MALIGNANT TUMORS OF THE UPPER RESPIRATORY TRACT AND THE EAR].
    SVETLAKOV MI; KRAVCHENKO AA
    Vestn Otorinolaringol; 1964; 26():49-53. PubMed ID: 14252954
    [No Abstract]   [Full Text] [Related]  

  • 5. [Changes in erythropoiesis in patients with malignant tumors of the ovaries during chemotherapy].
    Bruk AA; Loskutova GP; Turbina IL
    Vopr Onkol; 1967; 13(12):21-3. PubMed ID: 4970401
    [No Abstract]   [Full Text] [Related]  

  • 6. [The state of hemopoiesis in the regional perfusion of malignant tumors of the extremities with sarcolysin, thio-TEPA and cyclophosphane].
    Levin AO; Babinina VF
    Vopr Onkol; 1967; 13(2):48-54. PubMed ID: 4971006
    [No Abstract]   [Full Text] [Related]  

  • 7. Phase I study of high-dose busulfan, melphalan and thiotepa with autologous stem cell support in patients with refractory malignancies.
    Weaver CH; Bensinger WI; Appelbaum FR; Lilleby K; Sandmaier B; Brunvand M; Rowley S; Petersdorf S; Rivkin S; Gooley T
    Bone Marrow Transplant; 1994 Nov; 14(5):813-9. PubMed ID: 7889015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fatal bone marrow aplasia due to endovesical thio-tepa].
    Navas P; Grasset D
    J Urol Nephrol (Paris); 1973 Dec; 79(12 Pt 2):489-91. PubMed ID: 4216649
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinico-electrocardiographic changes during perfusion chemotherapy of malignant tumors of the extremities].
    Levin AO; Volodkovich HG
    Vopr Onkol; 1970; 16(8):3-7. PubMed ID: 4993603
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experimental study of antitumor action of rubomycin in combination with some cytostatic compounds].
    Rossolimo OK; Lepeshkina GN
    Antibiotiki; 1967 Mar; 12(3):206-12. PubMed ID: 4969789
    [No Abstract]   [Full Text] [Related]  

  • 11. [MEDULLARY APLASIA DURING THE USE OF 4 ANTIMITOTICS: CARYOLYSIN, MYLERAN, THIOTEPA, ENDOXAN (APROPOS OF 32 CASES)].
    PLAUCHU M; DALMAIS J; GUINGAND M
    J Med Lyon; 1963 Dec; 44():1811-65. PubMed ID: 14126897
    [No Abstract]   [Full Text] [Related]  

  • 12. Muscle relaxants, myasthenia, and mustards?
    Bennett EJ; Schmidt GB; Patel KP; Grundy EM
    Anesthesiology; 1977 Mar; 46(3):220-1. PubMed ID: 402869
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy of concurrent chemoradiotherapy for T1 and T2 laryngeal squamous cell carcinoma regarding organ preservation.
    Nishimura G; Tsukuda M; Mikami Y; Matsuda H; Horiuchi C; Taguchi T; Takahashi M; Kawakami M; Watanabe M; Niho T; Abo H; Yamomoto S
    Anticancer Res; 2009 Feb; 29(2):661-6. PubMed ID: 19331217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of various aminothiol compounds on the toxicity and specific activity of antitumor preparations].
    Spasskaia IG; Iurchenko NIa; Rachinskiĭ FIu
    Vopr Onkol; 1968; 14(10):75-9. PubMed ID: 5724801
    [No Abstract]   [Full Text] [Related]  

  • 15. [Some peculiarities in the course of systemic diseases of haematopoietic organs in the process of chemotherapy].
    Reĭzinger MA
    Vopr Onkol; 1966; 12(1):18-22. PubMed ID: 5339898
    [No Abstract]   [Full Text] [Related]  

  • 16. Mobilized peripheral blood progenitor cells (PBPC) in support of tandem cycles of high-dose chemotherapy (HDC).
    Meisenberg BR; Miller WE; McMillan R
    Bone Marrow Transplant; 1996 Dec; 18(6):1087-93. PubMed ID: 8971377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-conditioning regimens consisting of thiotepa, melphalan and busulfan with stem cell rescue for the treatment of pediatric solid tumors.
    Hara J; Osugi Y; Ohta H; Matsuda Y; Nakanishi K; Takai K; Fujisaki H; Tokimasa S; Fukuzawa M; Okada A; Okada S
    Bone Marrow Transplant; 1998 Jul; 22(1):7-12. PubMed ID: 9678789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Application of prospidin in the treatment of patients with cancer of the larynx].
    Pogosov VS; Chernov VA; Antoiv VF
    Vestn Otorinolaringol; 1970; 32(1):57-61. PubMed ID: 5448717
    [No Abstract]   [Full Text] [Related]  

  • 19. Chemotherapy of ovarian cancer with melphalan.
    Rutledge F
    Clin Obstet Gynecol; 1968 Jun; 11(2):354-66. PubMed ID: 4971815
    [No Abstract]   [Full Text] [Related]  

  • 20. [Safe handling of nitrogen mustard. Risks for nurses in the treatment of mycosis fungoides].
    Cooijmans AC; Lensink JG; van Vloten WA
    TVZ; 1993 Feb; (4):143-7. PubMed ID: 8484873
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.